Global POC HbA1C Testing Market Growth (Status and Outlook) 2025-2031

Global POC HbA1C Testing Market Growth (Status and Outlook) 2025-2031

Product Code:1290872

Published Date: Mar 13,2025

Pages: 106

Region: Global

Category: Medical Devices & Consumables

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

The global POC HbA1C Testing market size is predicted to grow from US$ 580 million in 2025 to US$ 980 million in 2031; it is expected to grow at a CAGR of 9.1% from 2025 to 2031.

HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes. HbA1c is your average blood glucose (sugar) levels for the last two to three months. The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels and point-of-care (POC) instruments, characterized as fast, portable, and easy-to-use, have been shown to be suitable for providing rapid feedback of HbA1c levels. In this report, we mainly study the devices for POC HbA1C Testing without services.

Market Drivers:
The growing prevalence of diabetes worldwide is a key driver for the POC HbA1c testing market. As the number of diabetic and prediabetic patients continues to rise, there is an increasing need for quick and efficient monitoring solutions to manage blood sugar levels effectively. POC HbA1c testing provides immediate results, allowing for real-time clinical decision-making and reducing patient dependence on centralized laboratories. Additionally, advancements in technology have led to the development of highly accurate, portable, and user-friendly devices, expanding their adoption in hospitals, clinics, and even home settings. Government initiatives promoting early diabetes detection and personalized treatment plans further boost market growth.

Market Challenges:
Despite its advantages, POC HbA1c testing faces several challenges, including high costs and reimbursement limitations in some healthcare systems, which may hinder widespread adoption. Additionally, variations in accuracy and standardization among different POC devices pose concerns regarding result reliability, especially when compared to laboratory-based testing. Regulatory approvals and compliance with stringent quality standards also create barriers for manufacturers entering new markets. Furthermore, lack of awareness and limited access to POC testing in certain developing regions restricts its potential reach, requiring further investments in education and healthcare infrastructure.

LPI (LP Information)' newest research report, the “POC HbA1C Testing Industry Forecast” looks at past sales and reviews total world POC HbA1C Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected POC HbA1C Testing sales for 2025 through 2031. With POC HbA1C Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world POC HbA1C Testing industry.

This Insight Report provides a comprehensive analysis of the global POC HbA1C Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on POC HbA1C Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global POC HbA1C Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for POC HbA1C Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global POC HbA1C Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of POC HbA1C Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Immunoassay
    Boronate Affinity
    Others

Segmentation by Application:
    Hospital and Clinics
    Diagnostic Laboratories
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Abbott
    Siemens Healthineers
    Roche
    Bio-Rad
    GREEN CROSS MEDIS
    Trinity Biotech
    HUMAN Diagnostics
    Sinocare (PTS Diagnostics)
    Erba Diagnostics
    EKF Diagnostics
    OSANG Healthcare
    SD Biosensor
    Aidian
    Boditech Med
    i-SENS